Is RSH.AX stock a buy after the recent drop?

RSH.AX stock may be a tactical buy for short-term traders if a bounce is confirmed by volume and a move above A$0.04. For longer-term investors, fundamentals remain weak and the position carries high risk.

What are realistic price targets for RSH.AX stock?

Short-term traders can target **A$0.05** and **A$0.08** for partial exits on a confirmed bounce. Meyka AI's one-year model target is **A$0.06186**; this is a model projection, not a guarantee.

How does sector performance affect RSH.AX stock outlook?

Healthcare is tracking modest gains, which gives neutral tailwinds for small medical-device names like Respiri. Significant sector strength would improve sentiment, but RSH.AX needs company-specific catalysts to sustain gains.

What are the main risks when trading RSH.AX stock?

Primary risks include continued losses (EPS -0.01), thin liquidity, stretched valuation ratios, and negative professional ratings. Use small sizing and strict stops when trading RSH.AX stock.

AU Stocks

RSH.AX Respiri Limited ASX A$0.033 pre-market 20 Jan 2026: Oversold bounce setup

ByDanny Kontos January 19, 2026

RSH.AX stock is trading at A$0.033 pre-market on 20 Jan 2026, marking an oversold entry point for short-term traders. Respiri Limited (RSH.AX) on the ASX shows volume 579,396 versus an average 870,341, and a one-year range of A$0.02–A$0.10. The company reports EPS -0.01 and PE -3.30, underlining a loss-making profile but also a thin float where small flows can trigger sharp bounces. As an oversold bounce idea we focus on tight risk control, realistic targets, and catalysts tied to sector news and upcoming reporting windows.